Investment Summary |
|
|---|---|
| Date | 2016-01-01 |
| Target | Prolacta Bioscience |
| Sector | Life Science |
| Investor(s) |
Aisling Capital
Health Evolution Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 1.8B USD |
| Size | Large |
| Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 36 of 56 |
| Sector: Life Science M&A | 26 of 42 |
| Type: Venture M&A Deals | 22 of 29 |
| Country: Australia M&A | 1 of 1 |
| Year: 2016 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-01 |
Promentis Pharmaceuticals
Milwaukee, Wisconsin, United States Promentis Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system disorders of System XC. Promentis Pharmaceuticals was founded in 2007 and is based in Milwaukee, Wisconsin. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-12 |
Syros Pharmaceuticals
Cambridge, Massachusetts, United States Syros Pharmaceuticals is a biopharmaceutical company applying a pioneering approach to discover and develop medicines that control the expression of genes with the aim of treating cancer and other serious diseases. |
Buy | - |
Health Evolution Partners was a private investment firm focused on investing in rapidly growing healthcare companies. The Firm targeted opportunities across all sectors of the healthcare industry including hospitals, physicians, managed care, pharmaceutical developers, device makers, and consumer products/services. Health Evolution Partners was established in 2007 and was headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Venture M&A Deals | 1 of 1 |
| Country: Australia M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-07 |
Optimal IMX
Nashville, Tennessee, United States Optimal IMX, Inc. is a provider of professional radiology services to hospitals nationwide. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-23 |
Kisimul
Lincoln, United Kingdom Kisimul is a provider of residential education and care services to children and adults with severe learning difficulties, autism, challenging behaviour, Asperger syndrome and other related disabilities. Kisimul was founded in 1977 and is based in Lincoln, United Kingdom. |
Sell | - |
